Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks

J Matern Fetal Neonatal Med. 2005 May;17(5):353-6. doi: 10.1080/14767050500140370.

Abstract

Objective: To study changes in the expression rate of PIBF by peripheral lymphocytes in healthy pregnant women after administration of mifepristone for non-surgical termination of pregnancy at 5-8 wks of gestation.

Methods: Patients requesting early social termination of pregnancy, in a 3-month period, were included. A first venous blood sample was taken before oral administration of 600 mg of mifepristone (day 0). A second venous blood sample was taken 2 days later. PIBF on lymphocytes was determined by immunocytochemistry using a PIBF-specific polyclonal antibody.

Results: Termination of pregnancy was successful and complete in all cases. In 17 out of 21 patients, the percentage of PIBF positive lymphocytes decreased after anti-progesterone administration. The percentage of PIBF-expressing lymphocytes significantly decreased from 52.8%+/-21.6% (day 0) to 39.8%+/-18.2% by day 2 (p=0.001).

Conclusions: These data suggest a strong relationship between early termination of pregnancy induced with mifepristone and disturbances of progesterone-mediated immunosuppression.

Publication types

  • Evaluation Study

MeSH terms

  • Abortifacient Agents, Steroidal / administration & dosage
  • Abortifacient Agents, Steroidal / pharmacology*
  • Abortion, Induced*
  • Administration, Oral
  • Adult
  • Female
  • Humans
  • Lymphocytes / drug effects*
  • Mifepristone / administration & dosage
  • Mifepristone / pharmacology*
  • Pregnancy
  • Pregnancy Proteins / drug effects*
  • Pregnancy Trimester, First
  • Suppressor Factors, Immunologic / administration & dosage*

Substances

  • Abortifacient Agents, Steroidal
  • PIBF1 protein, human
  • Pregnancy Proteins
  • Suppressor Factors, Immunologic
  • Mifepristone